CoChat

Racemization: Its Biological Significance on Neuropathogenesis of Alzheimer's Disease.

Open access
MORI, HIROSHI, ISHII, KAZUHIRO, TOMIYAMA, TAKAMI, FURIYA, YOSHIKO, SAHARA, NARUHIKO, ASANO, SATOSHI, ENDO, NORIAKI, SHIRASAWA, TAKUJI, TAKIO, KOJI · 1994 · The Tohoku Journal of Experimental Medicine
Cited by 56

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Amyloid beta protein (A beta) in neuritic plaques of Alzheimer's disease has been found to be racemized and/or isomerized at their Asp residues. To elucidate the effect of racemization on the aggregation properties of A beta, we synthesized three kinds of A beta peptides in which D-Asp was substituted for L-Asp residues, i.e, normal A beta 1-40, [D-Asp7]A beta 1-40 and [D-Asp23]A beta 1-40. The aggregation and fibril formation of each peptide was examined by means of spectrofluorometry and electron microscopy. Of the three peptides, normal A beta showed the gradual increase of aggregation while [D-Asp7]A beta 1-40 and [D-Asp23] A beta 1-40 showed more enhanced aggregation at the final stage when the fibril formations were detected in all peptides solutions by electron microscopy. A comparative immunohistochemical study by anti-racemized A beta antibody and anti-A beta 1-42/43 antibody further showed the in vivo incorporation of D-Asp in senile plaques of Alzheimer's disease brains, which may be involved in plaque formation at the later stage than the deposition of the longer form of A beta (A beta 1-42/43). Taken together with the recent accumulated evidence on the aggregation mechanisms of A beta, the data presented here suggest that racemization may occur after the amyloid fibril formation but enhance the aggregation process by shifting the equilibrium of A beta from the soluble form to the insoluble form in Alzheimer's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1620/tjem.174.251

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 56

Metadata

Authors
MORI, H., ISHII, K., TOMIYAMA, T., FURIYA, Y., SAHARA, N., ASANO, S., ENDO, N., SHIRASAWA, T., & TAKIO, K.
Venue
The Tohoku Journal of Experimental Medicine
Published
1994
Volume
174
Issue
3
Pages
251-262
ISSN
  • 0040-8727 (ISSN-L)
  • 1349-3329
OpenAlex
W1978858878
Cited by
56
References
11
FWCI
0.64
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Racemization: Its Biological Significance on Neuropathogenesis of Alzheimer's Disease. https://app.cochat.ai/papers/10.1620/tjem.174.251
The paper
MORI, H., ISHII, K., TOMIYAMA, T., FURIYA, Y., SAHARA, N., ASANO, S., ENDO, N., SHIRASAWA, T., & TAKIO, K. (1994). Racemization: Its Biological Significance on Neuropathogenesis of Alzheimer's Disease. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.174.251

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.